Nevada
|
|
000-27243
|
|
03-7392107
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission File No.)
|
|
(IRS Employee Identification No.)
|
Large accelerated filer o
|
Accelerated Filer o
|
|
Non-accelerated filer o
|
Smaller reporting company x
|
|
(Do not check if a smaller reporting company)
|
Title Of Securities To be Registered
|
Amount
to be
Registered
|
Proposed
Maximum
Offering Price
Per Share
|
Proposed
Maximum
Aggregate
Offering Price (4)
|
Amount
of
Registration
Fee(1)
|
||||||||||||
Common Stock, $0.001(1)
|
3,500,000 | (2) | $ | 0.025 | (3) | $ | 87,500 | $ | 14.97 |
|
(1)
|
Estimated pursuant to Rule 457(o) under the Securities Act of 1933 solely for the purpose of computing the amount of the registration fee.
|
|
(2)
|
Representing shares of the Company to be offered through an equity financing arrangement and shares to be sold by the Selling Security Holder.
|
|
(3)
|
Based on Rule 457 under the Securities Act.
|
|
(4)
|
This amount represents the maximum aggregate value of common stock which may be drawn from the Underwriter by the registrant pursuant to the terms and conditions of a Drawdown Equity Financing Agreement between the Underwriter and the registrant.
|
iv
|
||
1.
|
1-1
|
|
1-3
|
||
1-6
|
||
1-7
|
||
1-10
|
||
1-14
|
||
1-14
|
||
1-14
|
||
1-17
|
||
1-18
|
||
1-18
|
||
1-19
|
||
1-23
|
||
1-23
|
||
1-23
|
||
1-23
|
||
1-24
|
||
1-26
|
||
1-28
|
||
1-29
|
||
1-29
|
||
1-29
|
||
1-31
|
||
1-32
|
||
1-58
|
||
2.
|
2-1
|
|
2-1
|
||
2-1
|
||
2-2
|
||
2-2
|
||
2-2
|
||
3.
|
3-5
|
|
·
|
The shares delivered to the Investor must be done so through a Deposit/Withdrawal at Custodian (DWAC) from a Deposit Trust Company and shares must have proof that they are free of restrictive legends.
|
|
·
|
The Company’s Registration Statement with respect to the resale of the shares of Common Stock delivered in connection with the Advance shall have been declared
|
|
·
|
The Company shall have obtained all material permits and qualifications required by any applicable state for the offer and sale of the Registrable Securities..
|
|
·
|
The Company shall have filed with the SEC in a timely manner all reports, notices and other documents required.
|
|
·
|
All fees set forth in Section 12. 4 of the DEFA shall have been paid or withheld.
|
|
·
|
The Company’s transfer agent is DWAC eligible.
|
Payments for Each Number of Days Overdue
|
$10,000 Worth of Common Stock
|
1
|
$100
|
2
|
$200
|
3
|
$300
|
4
|
$400
|
5
|
$500
|
6
|
$600
|
7
|
$700
|
8
|
$800
|
9
|
$900
|
10
|
$1000
|
Over 10
|
$1000 + $200 for each Business Day beyond the tenth day
|
Common stock offered:
|
Up to 3,500,000 shares of common stock, no par value, to be offered for resale by Auctus.
|
|
Common stock to be outstanding after this offering:
|
43,960,782 shares to be outstanding after this offering
|
|
Use of proceeds:
|
We will not receive any proceeds from the sale of the shares of common stock offered by Auctus. However, we will receive proceeds from the Equity Line of Credit. See “Use of Proceeds”.
|
|
Risk factors:
|
An investment in our common stock involves a high degree of risk. See “Risk Factors” of this prospectus.
|
|
OTC Bulletin Board symbol:
|
“CYIO.OB”
|
|
·
|
terminate current contracts at any time for the convenience of the government, provided such termination is made in good faith;
|
|
·
|
cancel multi-year contracts and related orders if funds for contract performance for any subsequent year become unavailable;
|
|
·
|
curtail or modify current contracts if requirements or budgetary constraints change; and
|
|
·
|
adjust contract costs and fees on the basis of audits done by its agencies.
|
|
·
|
the Federal Acquisition Regulations and their supplements, which regulate the formation, administration and performance of federal government contracts;
|
|
·
|
the Truth in Negotiations Act, which requires certification and disclosure of cost and pricing data in connection with contract negotiations; and
|
|
·
|
the Cost Accounting Standards, which impose accounting requirements that govern our right to reimbursement under certain cost-based government contracts.
|
|
·
|
the trading volume of our shares;
|
|
·
|
the number of securities analysts, market-makers and brokers following our common stock;
|
|
·
|
changes in, or failure to achieve, financial estimates by securities analysts;
|
|
·
|
new products or services introduced or announced by us or our competitors;
|
|
·
|
actual or anticipated variations in quarterly operating results;
|
|
·
|
conditions or trends in our business industries;
|
|
·
|
announcements by us of significant contracts, acquisitions, strategic partnerships, joint ventures or capital commitments;
|
|
·
|
additions or departures of key personnel;
|
|
·
|
sales of our common stock; and
|
|
·
|
general stock market price and volume fluctuations of publicly-traded, and particularly microcap, companies.
|
|
·
|
deliver to a prospective investor a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market;
|
|
·
|
provide the prospective investor with current bid and ask quotations for the penny stock;
|
|
·
|
explain to the prospective investor the compensation of the broker-dealer and its salesperson in the transaction;
|
|
·
|
provide investors monthly account statements showing the market value of each penny stock held in the their account; and
|
|
·
|
make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction.
|
|
·
|
Our limited operating history and business development associated with being a growth stage company;
|
|
·
|
General economic and capital market conditions;
|
|
·
|
Our history of operating losses, which we expect to continue;
|
|
·
|
Our exposure to unanticipated and uncontrollable business interruptions;
|
|
·
|
Our ability to generate enough positive cash flow to pay our creditors and continue our operations;
|
|
·
|
Pricing and product actions taken by our competitors in either our organ and tissue preservation or alternative energy markets;
|
|
·
|
Our dependence on key personnel;
|
|
·
|
Financial condition of our prospective customers;
|
|
·
|
Our need to attract and retain technical and managerial personnel;
|
|
·
|
Customers’ perception of our financial condition relative to that of our competitors;
|
|
·
|
Our ability to execute our business strategy;
|
|
·
|
Changes in United States or foreign tax laws or regulations;
|
|
·
|
Our ability to protect our intellectual property and proprietary technologies;
|
|
·
|
Unforeseen liabilities resulting from litigation;
|
|
·
|
Costs associated with potential infringement claims asserted by a third party;
|
|
·
|
Our ability to successfully complete the integration of any future acquisitions; and ability to protect, and build recognition of, our trademarks and trade names;
|
|
·
|
Our ability to project the markets for our products and services based upon estimates and assumptions.
|
|
Proceeds if 100% shares
sold
|
Proceeds if 50%
sold
|
||||||
Gross proceeds
|
87,500 | 43,750 | ||||||
Offering expenses:
|
||||||||
Legal fees
|
5,000 | 2,500 | ||||||
Printing of prospectus
|
1,000 | 1,000 | ||||||
Accounting and auditing fees
|
1,000 | 1,000 | ||||||
Marketing and cost of sales
|
79,800 | 38,550 | ||||||
Transfer agent fees
|
500 | 500 | ||||||
Miscellaneous expenses
|
200 | 200 | ||||||
Total offering expenses
|
87,500 | 43,750 | ||||||
Net proceeds
|
-0- | -0- |
Price per share
|
$ | 0.025 | ||
Net tangible book value per share before offering
|
$ | 332,193 | ||
Potential gain to existing shareholders
|
$ | 87,500 | ||
Net tangible book value per share after offering
|
$ | 419,693 | ||
Increase to present shareholders in net tangible book value per share after offering
|
$ | 87,500 | ||
Capital contributions
|
$ | 87,500 | ||
Number of shares outstanding before the Offering
|
35,698,877 | |||
Number of shares after Offering assuming the sale of 100% of shares offered
|
39,198,877 | |||
Percentage ownership after Offering
|
91.07 | % |
Price per share
|
$ | 0.025 | ||
Dilution per share
|
$ | 0.01 | ||
Capital Contributions
|
$ | 87,500 | ||
Number of shares after Offering held by public investors
|
39,198,877 | |||
Percentage of capital contributions by existing shareholders
|
79.15 | % | ||
Percentage of capital contributions by new investors
|
20.85 | % | ||
Percentage of ownership after Offering
|
8.93 | % |
Price per share
|
$ | 0.0125 | ||
Dilution per share
|
$ | 0.00 | ||
Capital Contributions
|
$ | 43,750 | ||
Number of shares after Offering held by public investors
|
39,198,877 | |||
Percentage of capital contributions by existing shareholders
|
88.36 | % | ||
Percentage of capital contributions by new investors
|
11.64 | % | ||
Percentage of ownership after Offering
|
8.93 | % |
Price per share
|
$ | 0.00625 | ||
Dilution per share
|
$ | 0.00 | ||
Capital Contributions
|
$ | 21,875 | ||
Number of shares after Offering held by public investors
|
39,198,877 | |||
Percentage of capital contributions by existing shareholders
|
93.82 | % | ||
Percentage of capital contributions by new investors
|
6.18 | % | ||
Percentage of ownership after Offering
|
8.93 | % |
Net cash payments to CYIOS from Auctus
|
||||
If 100% (3,500,000) of shares sold at $.025 market price per share:
|
||||
Total proceeds
|
$ | 87,500 | ||
less fee to Auctus--6%
|
$ | 5,250 | ||
Total net payments to Company
|
$ | 82,250 | ||
If 100% (3,500,000) of shares sold at $.0125 market price per share (a 50% decrease):
|
||||
Total proceeds
|
$ | 43,750 | ||
less fee to Auctus--6%
|
$ | 2,625 | ||
Total net payments to Company
|
$ | 41,125 | ||
If 100% (3,500,000) of shares sold at $.00625 market price per share (a 75% decrease):
|
||||
Total proceeds
|
$ | 21,875 | ||
less fee to Auctus--6%
|
$ | 1,313 | ||
Total net payments to Company
|
$ | 20,562 |
Name
|
Number of Shares
Beneficially Owned Prior to Offering (1)
|
Number of
Shares Offered
|
Number of Shares
Beneficially Owned
after the Offering
|
|||||||||
Auctus Private Equity Fund, LLC (2)
|
100,000 | 3,500,000 | 0 |
Year Ended December 31, 2009
|
Year Ended December 31, 2008
|
|||||||||||||||
High
|
Low
|
High
|
Low
|
|||||||||||||
First Quarter
|
$ | 0.11 | $ | 0.09 | $ | 0.13 | $ | 0.10 | ||||||||
Second Quarter
|
$ | 0.13 | $ | 0.12 | $ | 0.10 | $ | 0.09 | ||||||||
Third Quarter
|
$ | 0.08 | $ | 0.07 | $ | 0.06 | $ | 0.05 | ||||||||
Fourth Quarter
|
$ | 0.06 | $ | 0.05 | $ | 0.04 | $ | 0.03 |
Equity Compensation Plan Information
|
||||||||||||
Number of securities to be issued upon exercise of outstanding options, warrants
|
Weighted-average exercise price of outstanding options, warrants and rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
||||||||||
Plan Category
|
(a)
|
(b)
|
(c)
|
|||||||||
Equity compensation plans approved by security holders
|
— | — | — | |||||||||
Equity compensation plans not approved by security holders
|
— | — | 35,700 | |||||||||
Total
|
— | — | 35,700 |
|
·
|
Contains a description of the nature and level of risk in the market for penny stock in both Public offerings and secondary trading;
|
|
·
|
Contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation of such duties or other requirements of the Securities Act of 1934, as amended;
|
|
·
|
Contains a brief, clear, narrative description of a dealer market, including “bid” and “ask” price for the penny stock and the significance of the spread between the bid and ask price;
|
|
·
|
Contains a toll-free number for inquiries on disciplinary actions;
|
|
·
|
Defines significant terms in the disclosure document or in the conduct of trading penny stocks; and
|
|
·
|
Contains such other information and is in such form (including language, type, size and format) as the Securities and Exchange Commission shall require by rule or regulation.
|
|
·
|
The bid and offer quotations for the penny stock;
|
|
·
|
The compensation of the broker-dealer and its salesperson in the transaction;
|
|
·
|
The number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and
|
|
·
|
Monthly account statements showing the market value of each penny stock held in the customer’s account.
|
|
·
|
Depreciation charges of $196;
|
|
·
|
Stock based compensation in the amount of $374,000;
|
|
·
|
Working capital changes of $63,426, consisting of a net increase of $65,705 in Accounts Receivable and Other Assets and a net increase of $2,279 in Accrued Expenses, Payroll Taxes Payable, and Accounts Payable.
|
|
·
|
Proceeds from the issuance of a Convertible Note Payable in the amount of $50,000 less.
|
|
·
|
Payments made on the Line of Credit in the amount of $4,827.
|
As of March 31,
|
||||||||
2010
|
2009
|
|||||||
Balance Sheet Data:
|
||||||||
Cash and cash equivalents
|
$ | 31,961 | $ | 7,232 | ||||
Property and equipment net of depreciation
|
2,024 | 2,808 | ||||||
Total assets
|
550,266 | 410,077 | ||||||
Total liabilities
|
218,073 | 197,882 | ||||||
Stockholders’ Equity
|
332,193 | 212,195 |
For the 3 months ending March 31,
|
||||||||
2010
|
2009
|
|||||||
Revenues
|
$ | 446,276 | $ | 374,923 | ||||
Total cost and expenses
|
845,366 | 367,562 | ||||||
Other Income (Expense)
|
(1,340 | ) | (3,598 | ) | ||||
Net Loss from Continuing Operations
|
(400,430 | ) | 3,763 | |||||
Net Income (Loss)
|
(400,430 | ) | 3,763 | |||||
Net Income/(Loss) per share—basic and fully diluted
|
$ | 0.00 | $ | 0.00 |
Name
|
Age
|
Position
|
Timothy W. Carnahan
|
42
|
Director, Chief Executive Officer and Treasurer
|
|
·
|
any bankruptcy petition filed by or against any business of which such person was an executive officer either at the time of the bankruptcy or within two years prior to that time;
|
|
·
|
any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
|
|
·
|
being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; and
|
|
·
|
being found by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
|
|
·
|
Any judicial or administrative proceedings resulting from involvement in mail or wire fraud or fraud in connection with any business entity;
|
|
·
|
Any judicial or administrative proceedings based on violations of federal or state securities, commodities, banking or insurance laws and regulations, or any settlement114 to such actions; and
|
|
·
|
Any disciplinary sanctions or orders imposed by a stock, commodities or derivatives
|
|
·
|
exchange or other self-regulatory organization.
|
Summary Compensation Table
|
|||||||||||||||||||||||||||||||||
Name and principal position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock Awards
($)
|
Option Awards
($)
|
Non-Equity Incentive Plan Compensation
($)
|
Non-qualified Deferred Compensation Earnings
($)
|
All Other Compensation
($)
|
Total Compensation ($)
|
||||||||||||||||||||||||
Timothy Carnahan,
Chief Executive Officer
|
2009
|
$ | 151,534 | -- | -- | -- | -- | -- | -- | $ | 151,534 |
Outstanding Equity Awards at Fiscal Year-End
|
||||||||||||||||||||||||||||||||||||
Option Awards
|
Stock Awards
|
|||||||||||||||||||||||||||||||||||
Name
|
Number of securities underlying unexercised options (#) Exercisable
|
Number of securities underlying unexercised options (#)
Unexercisable
|
Equity Incentive Plan Awards: Number of Securities underlying unexercised unearned options (#)
|
Option exercise price ($)
|
Option expiration date
|
Number of shares or units of stock that have not vested (#)
|
Market value of shares or units of stock that have not vested ($)
|
Equity incentive plan awards: number of unearned shares, units or other rights that have not vested (#)
|
Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($)
|
|||||||||||||||||||||||||||
Timothy Carnahan, Chief Executive Officer
|
-- | -- | -- | -- | -- | -- | -- | -- | -- |
|
·
|
each person known by us to be the beneficial owner of more than 5% of our common stock;
|
|
·
|
each of our directors and executive officers; and
|
|
·
|
all of our directors and executive officers as a group.
|
Name and address of beneficial owner (1)
|
Amount and nature of beneficial ownership
|
Percent of Class
|
||||||
Timothy Carnahan
|
20,976,294 | 59.68 | % | |||||
All officers and directors as a group
|
20,976,294 | 59.68 | % |
(1)
|
The address of each person listed is care of CYIOS Corporation, 1300 Pennsylvania Avenue, Suite 700, Washington D.C. 20004.
|
Index to Consolidated Financial Statements
|
Page
|
Report of Independent Registered Public Accounting Firm
|
F-18
|
Consolidated Balance Sheet as of December 31, 2009 and 2008
|
F-21
|
Consolidated Statements of Operations for the Years Ended December 31, 2009 and 2008
|
F-22
|
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2009 and 2008
|
F-23
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2009 and 2008
|
F-24
|
Notes to the Consolidated Financial Statements
|
F-26
|
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Balance Sheets
|
||||||||
As of December 31,
|
||||||||
2009
|
2008
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS
|
||||||||
Cash and Cash Equivalents
|
$ | 76,448 | $ | 27,070 | ||||
Accounts Receivable
|
114,596 | 23,181 | ||||||
Prepaid and Other Current Assets
|
101,697 | 16,117 | ||||||
TOTAL CURRENT ASSETS
|
292,741 | 66,368 | ||||||
FIXED ASSETS, NET
|
2,220 | 3,004 | ||||||
OTHER ASSETS
|
||||||||
Related Party Loan
|
234,284 | 262,512 | ||||||
TOTAL OTHER ASSETS
|
234,284 | 262,512 | ||||||
TOTAL ASSETS
|
$ | 529,245 | $ | 331,884 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
LIABILITIES
|
||||||||
Current Liabilities:
|
||||||||
Line of Credit
|
$ | 71,100 | $ | 88,392 | ||||
Accounts Payable
|
4,045 | 46,113 | ||||||
Accruals and Other Payables
|
95,476 | 22,447 | ||||||
TOTAL LIABILITIES
|
170,621 | 156,952 | ||||||
STOCKHOLDERS' EQUITY
|
||||||||
Convertible Preferred Stock ($.001 par value, 5,000,000 authorized: 29,713 and 29,713 issued and outstanding)
|
30 | 30 | ||||||
Common Stock ($.001 par value, 100,000,000 shares authorized: 30,148,877 and 26,857,210 shares issued and outstanding)
|
30,149 | 26,857 | ||||||
Additional Paid-in-Capital
|
24,199,038 | 24,014,663 | ||||||
Accumulated Deficit
|
(23,870,593 | ) | (23,866,618 | ) | ||||
TOTAL STOCKHOLDERS' EQUITY
|
358,624 | 174,932 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 529,245 | $ | 331,884 |
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Statement of Operations
|
||||||||
For the years ended
December 31,
|
||||||||
2009
|
2008
|
|||||||
SALES AND COST OF SALES
|
||||||||
Sales
|
$ | 1,881,897 | $ | 1,494,872 | ||||
Cost of Sales
|
1,094,786 | 781,909 | ||||||
Gross Profit
|
787,111 | 712,963 | ||||||
EXPENSES
|
||||||||
Selling, general and administrative
|
68,884 | 179,371 | ||||||
Payroll Expense--Indirect Labor
|
598,225 | 521,681 | ||||||
Consulting and Professional Fees Expense
|
55,909 | 209,792 | ||||||
Consulting Expense--Stock Compensation
|
81,208 | |||||||
Depreciation
|
784 | 784 | ||||||
TOTAL EXPENSES
|
805,010 | 911,628 | ||||||
Net Income/(Loss) from Operations
|
(17,899 | ) | (198,665 | ) | ||||
OTHER INCOME/(EXPENSE)
|
||||||||
Interest Income
|
5,121 | 3,042 | ||||||
Interest Expense
|
(8,264 | ) | (7,106 | ) | ||||
NET OTHER INCOME/(EXPENSE)
|
(3,144 | ) | (4,064 | ) | ||||
PROVISION FOR INCOME TAXES
|
- | - | ||||||
NET INCOME/(LOSS) FROM CONTINUING OPERATIONS
|
(21,044 | ) | (202,729 | ) | ||||
NET INCOME/(LOSS) FROM DISCONTINUED OPERATIONS
|
17,068 | 256,497 | ||||||
Net Income/(Loss)
|
$ | (3,976 | ) | $ | 53,768 | |||
Net income/(loss) per share--basic and fully diluted
|
||||||||
Continuing Operations
|
$ | (0.00 | ) | $ | (0.01 | ) | ||
Discontinued Operations
|
$ | 0.00 | $ | 0.01 | ||||
Net income/(loss) per share
|
$ | (0.00 | ) | $ | 0.00 | |||
Weighted average shares outstanding--basic and fully diluted
|
27,828,635 | 25,802,841 |
CYIOS Corporation and Subsidiaries
|
||||||||||||||||||||||||||||
Consolidated Statements of Stockholders' Deficit
|
||||||||||||||||||||||||||||
Preferred
|
Preferred
|
Common
|
Common
|
Stock
|
Additional
|
|||||||||||||||||||||||
Shares
|
Stock
|
Shares
|
Stock
|
Subscription
|
Paid-in
|
Accumulated
|
||||||||||||||||||||||
(000's)
|
$ |
(000's)
|
$ |
Receivable
|
Capital
|
Deficit
|
||||||||||||||||||||||
Balances, December 31, 2007
|
29,713 | $ | 30 | 25,354,210 | $ | 25,354 | $ | 136,000 | $ | 23,886,536 | $ | (23,920,386 | ) | |||||||||||||||
Shares returned
|
- | - | (500,000 | ) | (500 | ) | (82,500 | ) | (74,500 | ) | - | |||||||||||||||||
Payments received for Stock Subscriptions
|
- | - | - | - | (48,500 | ) | - | - | ||||||||||||||||||||
Reduction for Uncollectible Stock Receivable
|
- | - | - | - | (5,000 | ) | (5,000 | ) | - | |||||||||||||||||||
Shares issued for consulting services
|
- | - | 2,003,000 | 2,003 | - | 207,627 | - | |||||||||||||||||||||
Net Income (loss)
|
- | - | - | - | - | 53,768 | ||||||||||||||||||||||
Balances, December 31, 2008
|
29,713 | $ | 30 | 26,857,210 | $ | 26,857 | $ | - | $ | 24,014,663 | $ | (23,866,618 | ) | |||||||||||||||
Shares issued for consulting services
|
- | - | 2,366,667 | 2,367 | - | 159,300 | - | |||||||||||||||||||||
Shares issued to employees
|
- | - | 125,000 | 125 | 5,875 | - | ||||||||||||||||||||||
Shares sold
|
- | - | 800,000 | 800 | - | 19,200 | - | |||||||||||||||||||||
Net Income (loss)
|
- | - | - | - | - | - | (3,976 | ) | ||||||||||||||||||||
Balances, December 31, 2009
|
29,713 | $ | 30 | 30,148,877 | $ | 30,149 | $ | - | $ | 24,199,038 | $ | (23,870,593 | ) |
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Statements of Cash Flows
|
||||||||
For the years ended
December 31,
|
||||||||
2009
|
2008
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net Income/(loss)
|
||||||||
From Continuing Operations
|
$ | (21,044 | ) | $ | (202,729 | ) | ||
From Discontinued Operations
|
17,068 | 256,497 | ||||||
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
Depreciation
|
784 | 784 | ||||||
Value of Shares Issued for consulting/employee services
|
167,667 | 209,630 | ||||||
Reduction in Stock Receivable
|
- | 7,500 | ||||||
Reduction in Liabilities from Discontinued Operations
|
(17,068 | ) | (256,497 | ) | ||||
Changes in Assets and Liabilities:
|
||||||||
(Increase)/Decrease in Accounts Receivable
|
(91,415 | ) | 23,216 | |||||
(Increase)/Decrease in Prepaid and Other Current Assets
|
(85,579 | ) | (11,217 | ) | ||||
Increase/(Decrease) in Accruals and Other Payables
|
73,029 | (15,073 | ) | |||||
Increase/(Decrease) in Accounts Payable
|
(25,000 | ) | 21,492 | |||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
18,442 | 33,603 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
(Increase)/Decrease in Related Party Loan
|
28,228 | (90,106 | ) | |||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
28,228 | (90,106 | ) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from Issuance of Common Stock
|
20,000 | - | ||||||
Proceeds Received from Payments made on Stock Subscription Receivable
|
- | 48,500 | ||||||
Payments on Line of Credit
|
(17,292 | ) | (10,425 | ) | ||||
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
2,708 | 38,075 | ||||||
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
49,378 | (18,428 | ) | |||||
CASH AND CASH EQUIVALENTS:
|
||||||||
Beginning of Period
|
27,070 | 45,498 | ||||||
End of Period
|
$ | 76,448 | $ | 27,070 | ||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
|
||||||||
CASH PAID DURING THE PERIOD FOR:
|
||||||||
Interest
|
$ | 8,264 | $ | 7,106 | ||||
Taxes
|
$ | - | $ | - | ||||
NON CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Stock Issued for Prepaid Consulting Services
|
$ | 89,833 | $ | - | ||||
Stock Issued for Consulting Services/Employee Bonus
|
$ | 77,834 | $ | 209,630 | ||||
Return of 500,000 shares and reduction in related Stock Receivable
|
$ | - | $ | 75,000 |
Total Deferred Tax Asset
|
$ | 2,264,327 | ||
Valuation Allowance
|
(2,264,327 | ) | ||
Net Deferred Tax Asset
|
- |
2009
|
2008
|
|||||||
Income tax computed at the federal statutory rate
|
34 | % | 34 | % | ||||
State income tax, net of federal tax benefit
|
0 | % | 0 | % | ||||
Total
|
34 | % | 34 | % | ||||
Valuation allowance
|
-34 | % | -34 | % | ||||
Total deferred tax asset
|
0 | % | 0 | % |
Net Sales by Segment
|
For the Year Ended December 31, 2009
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Sales, net
|
$ | 1,881,897 | $ | - | $ | - | $ | 1,881,897 | ||||||||
Cost of Sales
|
1,094,786 | - | - | 1,094,786 | ||||||||||||
Gross Profit
|
$ | 787,111 | $ | - | $ | - | $ | 787,111 | ||||||||
Profit/(Loss) by Segment
|
For the Year Ended December 31, 2009
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Net Operating Profit/(Loss)
|
$ | (13,119 | ) | $ | 2,331 | $ | (10,256 | ) | $ | (21,044 | ) | |||||
Net (Loss)
|
$ | (13,119 | ) | $ | 19,399 | $ | (10,256 | ) | $ | (3,976 | ) |
Net Sales by Segment
|
For the Year Ended December 31, 2009
|
|||||||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
WorldTeq
|
Totals
|
||||||||||||||||
Sales, net
|
$ | 1,494,872 | $ | - | $ | - | $ | - | $ | 1,494,872 | ||||||||||
Cost of Sales
|
781,909 | - | - | - | 781,909 | |||||||||||||||
Gross Profit
|
$ | 712,963 | $ | - | $ | - | $ | - | $ | 712,963 | ||||||||||
Profit/(Loss) by Segment
|
For the Year Ended December 31, 2009
|
|||||||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
WorldTeq
|
Totals
|
||||||||||||||||
Net Operating Profit/(Loss)
|
$ | (198,072 | ) | $ | (20 | ) | $ | (4,637 | ) | $ | - | $ | (202,729 | ) | ||||||
Net (Loss)
|
$ | (198,072 | ) | $ | (20 | ) | $ | (4,637 | ) | $ | 256,497 | $ | 53,768 |
Month/Description of transaction
|
Number of shares
|
Price per share
|
Total Value
|
|||||||||
January 29, 2009
|
100,000 | $ | 0.05 | $ | 4,500 | |||||||
January 29, 2009
|
550,000 | $ | 0.05 | $ | 27,500 | |||||||
February 9, 2009
|
25,000 | $ | 0.06 | $ | 1,500 | |||||||
May 1, 2009*
|
100,000 | $ | 0.14 | $ | 14,000 | |||||||
May 13, 2009
|
400,000 | $ | 0.05 | $ | 20,000 | |||||||
October 5, 2009
|
1,400,000 | $ | 0.07 | $ | 98,000 | |||||||
October 28, 2009
|
316,667 | $ | 0.07 | $ | 22,167 | |||||||
December 17, 2009*
|
400,000 | $ | - | $ | - | |||||||
Total
|
3,291,667 | $ | 187,667 |
Month
|
Number of shares
|
Price per share
|
Total Value
|
|||||||||
January 3, 2008
|
400,000 | $ | 0.23 | $ | 92,000 | |||||||
January 4, 2008
|
53,000 | $ | 0.21 | $ | 11,130 | |||||||
March 12, 2008
|
250,000 | $ | 0.10 | $ | 25,000 | |||||||
May 30, 2008
|
250,000 | $ | 0.10 | $ | 25,000 | |||||||
June 18, 2008
|
50,000 | $ | 0.08 | $ | 4,000 | |||||||
August 25, 2008
|
250,000 | $ | 0.06 | $ | 15,000 | |||||||
October 8, 2008
|
750,000 | $ | 0.05 | $ | 37,500 | |||||||
Total
|
2,003,000 | $ | 209,630 |
Stock/Options
|
Weighted average price per share
|
Aggregate intrinsic value
|
||||||||||
Outstanding at December 31, 2007
|
2,750,000 | 0.18 | 495,000 | |||||||||
For the year ended December 31, 2008
|
||||||||||||
Granted
|
2,003,000 | 0.18 | 360,540 | |||||||||
Options forfeited or expired
|
(335,716 | ) | 0.13 | (43,643 | ) | |||||||
Options forfeited or expired
|
(400,000 | ) | 0.29 | (116,000 | ) | |||||||
Exercised in 2008
|
(2,003,000 | ) | 0.18 | (360,540 | ) | |||||||
Outstanding at December 31, 2008
|
2,014,284 | 0.13 | 261,857 | |||||||||
For the period ended December 31, 2009
|
||||||||||||
Granted
|
3,291,667 | 0.06 | 197,500 | |||||||||
Options forfeited or expired
|
(2,014,284 | ) | 0.13 | (261,857 | ) | |||||||
Exercised in 2009
|
(3,291,667 | ) | 0.06 | (197,500 | ) | |||||||
Outstanding at December 31, 2009
|
— | 0.13 | — |
Plan Category
|
Number of shares available for issuance
|
Equity compensation approved by security holders
|
—
|
3
|
35,700
|
|
2010
|
$17,700
|
Year ended
|
Interest and principal payments
|
|||
2010
|
$ | 38,220 | ||
2011
|
38,220 | |||
2012
|
38,220 | |||
2013
|
38,220 | |||
2014
|
38,220 | |||
2015 and thereafter
|
130,564 | |||
Total principal and interest payments
|
$ | 321,664 |
CKO
|
$ | 44,729 | ||
CYIOS Group
|
26,371 | |||
$ | 71,100 |
|
1.
|
Some of the outstanding accounts payable had already been paid off by one of the other subsidiaries, but were never actually written off the books of the subsidiary (Worldteq) until now. The officers and managers of the company prior to the merger in 2005 provided the new officers and management with records that were incomplete. After careful review, management has concluded that some accounts outstanding had actually been paid, but not cleared off the books of the subsidiary (Worldteq).
|
|
2.
|
Using reasonable estimates, management determined that amounts under $1,000 were immaterial and exceeded the statute of limitations for the State of Delaware could be written-off as of December 31, 2008 and 2007.
|
|
3.
|
The officers and management of the company prior to the merger in 2005 calculated accruals based on estimates for expenses for services that were never rendered to the company.
|
For the 12 months ended December 31, 2009
|
For the 12 Months Ended December 31, 2008
|
|||||||||||||||||||||||
Income
|
Shares
|
Per-Share
|
Income
|
Shares
|
Per-Share
|
|||||||||||||||||||
(Numerator)
|
(Denominator)
|
Amount
|
(Numerator)
|
(Denominator)
|
Amount
|
|||||||||||||||||||
Net Income/(Loss)
|
$ | (3,976 | ) | $ | 53,768 | |||||||||||||||||||
Basic EPS
|
||||||||||||||||||||||||
Income available to common stockholders
|
(3,976 | ) | 27,798,922 | $ | (0.00 | ) | 53,768 | 25,744,896 | $ | 0.00 | ||||||||||||||
Effect of Dilutive Securities
|
||||||||||||||||||||||||
Warrants
|
||||||||||||||||||||||||
Convertible preferred stock
|
29,713 | 29,713 | ||||||||||||||||||||||
Diluted EPS
|
||||||||||||||||||||||||
Net Income/(Loss)
|
(3,976 | ) | 27,828,635 | $ | (0.00 | ) | 53,768 | 25,774,609 | $ | 0.00 |
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Balance Sheet
|
||||||||
As of
|
As of
|
|||||||
March 31,
|
December 31,
|
|||||||
2010--(unaudited)
|
2009--(audited)
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS
|
||||||||
Cash and Cash Equivalents
|
$ | 31,961 | $ | 76,448 | ||||
Accounts Receivable
|
169,160 | 114,596 | ||||||
Prepaid and Other Current Assets
|
112,837 | 101,697 | ||||||
TOTAL CURRENT ASSETS
|
313,958 | 292,741 | ||||||
FIXED ASSETS, NET
|
2,024 | 2,220 | ||||||
OTHER ASSETS
|
||||||||
Related Party Loan
|
234,284 | 234,284 | ||||||
TOTAL OTHER ASSETS
|
234,284 | 234,284 | ||||||
TOTAL ASSETS
|
$ | 550,266 | $ | 529,245 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
LIABILITIES
|
||||||||
Current Liabilities:
|
||||||||
Line of Credit
|
$ | 66,273 | $ | 71,100 | ||||
Convertible Note Payable
|
50,000 | - | ||||||
Accruals and Other Payables
|
101,800 | 99,521 | ||||||
TOTAL LIABILITIES
|
218,073 | 170,621 | ||||||
STOCKHOLDERS' EQUITY
|
||||||||
Convertible Preferred Stock ($.001 par value, 5,000,000 authorized:29,713 and 29,713 issued and outstanding)
|
30 | 30 | ||||||
Common Stock ($.001 par value, 100,000,000 shares authorized:35,698,877 and 30,148,877 shares issued and outstanding)
|
35,699 | 30,149 | ||||||
Additional Paid-in-Capital
|
24,567,488 | 24,199,038 | ||||||
Accumulated Deficit
|
(24,271,024 | ) | (23,870,593 | ) | ||||
TOTAL STOCKHOLDERS' EQUITY
|
332,193 | 358,624 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 550,266 | $ | 529,245 |
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Statement of Operations--(unaudited)
|
||||||||
For the three months ended March 31,
|
||||||||
2010
|
2009
|
|||||||
SALES AND COST OF SALES
|
||||||||
Sales
|
$ | 446,276 | $ | 374,923 | ||||
Cost of Sales
|
266,299 | 218,508 | ||||||
Gross Profit
|
179,977 | 156,415 | ||||||
EXPENSES
|
||||||||
Selling, general and administrative
|
28,254 | 17,869 | ||||||
Payroll Expense--Indirect Labor
|
158,070 | 110,933 | ||||||
Consulting and Professional Fees Expense
|
28,380 | 5,156 | ||||||
Payroll Expense--Stock Compensation
|
350,000 | 6,000 | ||||||
Consulting Expense--Stock Compensation
|
14,167 | 27,500 | ||||||
Depreciation
|
196 | 196 | ||||||
TOTAL EXPENSES
|
579,067 | 167,654 | ||||||
Net Income/(Loss) from Operations
|
(399,090 | ) | (11,239 | ) | ||||
OTHER INCOME/(EXPENSE)
|
||||||||
Interest Income
|
1,307 | 1,266 | ||||||
Interest Expense
|
(2,647 | ) | (4,864 | ) | ||||
NET OTHER INCOME/(EXPENSE)
|
(1,340 | ) | (3,598 | ) | ||||
PROVISION FOR INCOME TAXES
|
- | - | ||||||
NET INCOME/(LOSS) FROM CONTINUING OPERATIONS
|
(400,430 | ) | (14,837 | ) | ||||
Net Income/(Loss)
|
$ | (400,430 | ) | $ | (14,837 | ) | ||
Net income/(loss) per share--basic and fully diluted
|
||||||||
Net income/(loss) per share
|
$ | (0.01 | ) | $ | (0.00 | ) | ||
Weighted average shares outstanding--basic and fully diluted
|
$ | (0.01 | ) | $ | (0.00 | ) |
CYIOS Corporation and Subsidiaries
|
||||||||||||||||||||||||
Consolidated Statement of Stockholders' Equity—(unaudited)
|
||||||||||||||||||||||||
Preferred
|
Preferred
|
Common
|
Common
|
Additional
|
||||||||||||||||||||
Shares
|
Stock
|
Shares
|
Stock
|
Paid-in
|
Accumulated
|
|||||||||||||||||||
(000's)
|
$ |
(000's)
|
$ |
Capital
|
Deficit
|
|||||||||||||||||||
Balances, December 31, 2008
|
29,713 | $ | 30 | 26,857,210 | $ | 26,857 | $ | 24,014,663 | $ | (23,866,618 | ) | |||||||||||||
Shares issued for consulting services
|
- | - | 2,366,667 | 2,367 | 159,300 | - | ||||||||||||||||||
Shares issued to employees
|
- | - | 125,000 | 125 | 5,875 | - | ||||||||||||||||||
Shares sold
|
- | - | 800,000 | 800 | 19,200 | - | ||||||||||||||||||
Net Income (loss)
|
- | - | - | - | (3,976 | ) | ||||||||||||||||||
Balances, December 31, 2009
|
29,713 | $ | 30 | 30,148,877 | $ | 30,149 | $ | 24,199,038 | $ | (23,870,594 | ) | |||||||||||||
Shares issued for consulting services
|
- | - | 550,000 | 550 | 23,450 | - | ||||||||||||||||||
Shares issued to executive officer as a bonus
|
- | - | 5,000,000 | 5,000 | 345,000 | - | ||||||||||||||||||
Net Income (loss)
|
- | - | - | - | - | (400,430 | ) | |||||||||||||||||
Balances, March 31, 2010
|
29,713 | $ | 30 | 35,698,877 | $ | 35,699 | $ | 24,567,488 | $ | (24,271,024 | ) |
CYIOS Corporation and Subsidiaries
|
||||||||
Consolidated Statements of Cash Flows—(unaudited)
|
||||||||
For the three months ended
|
||||||||
March 31,
|
||||||||
2010
|
2009
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net Income/(loss)
|
||||||||
From Continuing Operations
|
$ | (400,430 | ) | $ | (14,837 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in)operating activities:
|
||||||||
Depreciation
|
196 | 196 | ||||||
Value of Shares Issued for consulting/employee services
|
356,000 | 33,500 | ||||||
Changes in Assets and Liabilities:
|
||||||||
(Increase)/Decrease in Accounts Receivable
|
(54,564 | ) | (104,055 | ) | ||||
(Increase)/Decrease in Prepaid and Other Current Assets
|
6,859 | (14,390 | ) | |||||
Increase/(Decrease) in Accruals and Other Payables
|
6,324 | 49,524 | ||||||
Increase/(Decrease) in Accounts Payable
|
(4,045 | ) | 9,605 | |||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
(89,660 | ) | (40,457 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
(Increase)/Decrease in Related Party Loan
|
- | 20,218 | ||||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
- | 20,218 | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from Issuance of Common Stock
|
- | - | ||||||
Proceeds Received from Payments made on Stock Subscription Receivable
|
- | - | ||||||
Proceeds from Issuance of Convertible Note Payable
|
50,000 | - | ||||||
Principal Payments Made on line of Credit
|
(4,827 | ) | - | |||||
Proceeds Received from Draw on Line of Credit
|
- | 401 | ||||||
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
|
45,173 | 401 | ||||||
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
(44,487 | ) | (19,838 | ) | ||||
CASH AND CASH EQUIVALENTS:
|
||||||||
Beginning of Period
|
76,448 | 27,070 | ||||||
End of Period
|
$ | 31,961 | $ | 7,232 | ||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
|
||||||||
CASH PAID DURING THE PERIOD FOR:
|
||||||||
Interest
|
$ | 2,647 | $ | 4,864 | ||||
Taxes
|
$ | - | $ | - | ||||
NON CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Stock Issued for Prepaid Consulting Services
|
$ | 18,000 | $ | 27,500 | ||||
Stock Issued for Consulting Services/Employee Bonus
|
$ | 356,000 | $ | 6,000 |
Month/Description of transaction
|
Number of shares
|
Price per share
|
Total Value
|
|||||||||
March--Stock issued to Executive Officer as bonus
|
5,000,000 | $ | 0.07 | $ | 350,000 | |||||||
March--Stock issued for Consulting Services
|
100,000 | $ | 0.06 | $ | 6,000 | |||||||
March--Stock issued for Consulting Services
|
450,000 | $ | 0.04 | $ | 18,000 | |||||||
Total
|
5,550,000 | $ | 374,000 |
Stock/Options
|
Weighted average price per share
|
Aggregate intrinsic value
|
||||||||||
Outstanding at December 31, 2008
|
2,014,284 | 0.13 | 261,857 | |||||||||
For the year ended December 31, 2009
|
||||||||||||
Granted
|
3,291,667 | 0.06 | 197,500 | |||||||||
Options forfeited or expired
|
(2,014,284 | ) | 0.13 | (261,857 | ) | |||||||
Exercised in 2009
|
(3,291,667 | ) | 0.06 | (197,500 | ) | |||||||
Outstanding at December 31, 2009
|
- | 0.13 | - | |||||||||
For the period ended March 31, 2010
|
||||||||||||
Granted
|
- | - | - | |||||||||
Exercised in the first quarter 2010
|
- | - | - | |||||||||
Outstanding at March 31, 2010
|
- | - | - |
Total Deferred Tax Asset
|
$ | 2,264,327 | ||
Valuation Allowance
|
(2,264,327 | ) | ||
Net Deferred Tax Asset
|
- |
2009
|
2008
|
|||||||
Income tax computed at the federal statutory rate
|
34 | % | 34 | % | ||||
State income tax, net of federal tax benefit
|
0 | % | 0 | % | ||||
Total
|
34 | % | 34 | % | ||||
Valuation allowance
|
-34 | % | -34 | % | ||||
Total deferred tax asset
|
0 | % | 0 | % |
Net Sales by Segment
|
For the 3 months ended March 31, 2010
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Sales, net
|
$ | 446,276 | $ | - | $ | - | $ | 446,276 | ||||||||
Cost of Sales
|
266,299 | - | - | 266,299 | ||||||||||||
Gross Profit
|
$ | 179,977 | $ | - | $ | - | $ | 179,977 | ||||||||
Profit/(Loss) by Segment
|
For the 3 months ended March 31, 2010
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Net (Loss)
|
$ | (398,723 | ) | $ | - | $ | (1,707 | ) | $ | (400,430 | ) |
Net Sales by Segment
|
For the Three Months Ended March 31, 2009
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Sales, net
|
$ | 374,923 | $ | - | $ | - | $ | 374,923 | ||||||||
Cost of Sales
|
218,508 | - | - | 218,508 | ||||||||||||
Gross Profit
|
$ | 156,415 | $ | - | $ | - | $ | 156,415 | ||||||||
Profit/(Loss) by Segment
|
For the Three Months Ended March 31, 2009
|
|||||||||||||||
CYIOS
|
CYIOS Group
|
CKO
|
Totals
|
|||||||||||||
Net (Loss)
|
$ | (9,999 | ) | $ | (349 | ) | $ | (4,489 | ) | $ | (14,837 | ) |
Year-ended
|
Interest
|
Principal
|
||||||
2010
|
$ | 16,702 | $ | 11,996 | ||||
2011
|
$ | 16,958 | 17,153 | |||||
2012
|
$ | 15,534 | 18,576 | |||||
2013
|
$ | 13,992 | 20,118 | |||||
2014
|
$ | 12,322 | 21,788 | |||||
2015 and thereafter
|
$ | 31,310 | 144,653 | |||||
Total principal and interest payments
|
$ | 106,817 | $ | 234,284 |
For the 3 months ended March 31, 2010
|
For the 3 Months Ended March 31, 2009
|
|||||||||||||||||||||||
Income
|
Shares
|
Per-Share
|
Income
|
Shares
|
Per-Share
|
|||||||||||||||||||
(Numerator)
|
(Denominator)
|
Amount
|
(Numerator)
|
(Denominator)
|
Amount
|
|||||||||||||||||||
Net Income/(Loss)
|
$ | (400,430 | ) | $ | (14,837 | ) | ||||||||||||||||||
Basic EPS
|
||||||||||||||||||||||||
Income available to common stockholders
|
(400,430 | ) | 30,356,274 | $ | (0.01 | ) | (14,837 | ) | 27,011,526 | $ | 0.00 | |||||||||||||
Effect of Dilutive Securities
|
||||||||||||||||||||||||
Warrants
|
||||||||||||||||||||||||
Convertible preferred stock
|
29,713 | 29,713 | ||||||||||||||||||||||
Diluted EPS
|
||||||||||||||||||||||||
Net Income/(Loss)
|
(400,430 | ) | 30,385,987 | $ | (0.01 | ) | (14,837 | ) | 27,041,239 | $ | 0.00 |
CKO
|
$ | 43,400 | ||
CYIOS Group
|
22,873 | |||
$ | 66,273 |
Securities and Exchange Commission registration fee
|
$ | 14.97 | ||
Legal fees and expenses (1)
|
$ | 10,000 | ||
Accounting fees and expenses
|
$ | -- | ||
Miscellaneous (1)
|
$ | -- | ||
Total (1)
|
$ | 10,014.97 | ||
(1) Estimated
|
Exhibit
|
Description of Exhibit
|
Certificate of Incorporation
|
|
By-laws
|
|
Opinion of Counsel
|
|
Drawdown Equity Financing Agreement
|
|
Registration Rights Agreement
|
|
23.2
|
Consent of Counsel (included in Exhibit 5.1)
|
Consent of Independent Registered Certified Public Accountants
|
a.
|
The undersigned registrant hereby undertakes:
|
|
1.
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
i.
|
To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
|
|
ii.
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement.
|
|
iii.
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
|
|
A.
|
Paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement; and
|
|
B.
|
Paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
|
|
2.
|
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
3.
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
|
4.
|
If the registrant is a foreign private issuer, to file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Rule 3-19 of this chapter if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.
|
|
5.
|
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
|
|
i.
|
If the registrant is relying on Rule 430B:
|
|
a.
|
Each prospectus filed by the registrant pursuant to Rule 424(b)(3)shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
|
b.
|
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or
|
|
ii.
|
If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
|
6.
|
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
|
i.
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
|
|
ii.
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
|
|
iii.
|
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
|
|
iv.
|
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
|
b.
|
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
c.
|
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
|
|
CYIOS CORPORATION
|
|
|
|
|
By:
|
/s/ Timothy Carnahan
|
|
|
|
Timothy Carnahan
|
|
|
President, Chief Executive Officer &
Principal Financial Officer
|
Signature
|
Title
|
Date
|
||
/s/ Timothy Carnahan
|
President, Chief Executive Officer &
|
July 13, 2010
|
||
Timothy Carnahan
|
Principal Financial Officer
|